Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HAL SKOPICKI

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1346264553
CMS profile
333750
Location
ISLANDIA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$14,139.99

16 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $11,201.01 8
PFIZER INC. $2,854.84 3
Janssen Pharmaceuticals, Inc $48.07 3
Abbott Laboratories $24.41 1
Astellas Pharma US Inc $11.66 1

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HAL SKOPICKI

NPI 1346264553 · CMS profile ID 333750

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

ISLANDIA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1346264553?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1346264553?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1346264553?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1346264553?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

16 matching records · $14,139.99 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 16 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–16 of 16.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $114.0512/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673829509 CMS
Novartis Pharmaceuticals Corporation $207.9912/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660034517 CMS
Novartis Pharmaceuticals Corporation $3,300.0012/03/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660034519 CMS
Novartis Pharmaceuticals Corporation $124.7712/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660034521 CMS
PFIZER INC. $2,625.0011/14/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673834527 CMS
PFIZER INC. $115.7911/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673851405 CMS
Novartis Pharmaceuticals Corporation $727.3010/16/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660034511 CMS
Novartis Pharmaceuticals Corporation $3,300.0010/16/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660034513 CMS
Novartis Pharmaceuticals Corporation $119.8610/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660034515 CMS
Abbott Laboratories $24.4109/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 664505997 CMS
Janssen Pharmaceuticals, Inc $14.5106/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659299633 CMS
Janssen Pharmaceuticals, Inc $17.3805/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659299631 CMS
Novartis Pharmaceuticals Corporation $3,300.0004/11/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660034507 CMS
Novartis Pharmaceuticals Corporation $121.0904/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660034509 CMS
Janssen Pharmaceuticals, Inc $16.1804/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659299629 CMS
Astellas Pharma US Inc $11.6602/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655763981 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,139.99 16
PY2020 $647.26 8
PY2021 $12,069.00 12
PY2022 $2,586.05 5
PY2023 $295.23 4
PY2024 $443.71 6
PY2025 $308.21 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $123,059.53 14
PY2024 Principal investigator $131,886.60 14
PY2023 Principal investigator $177,782.25 13
PY2022 Principal investigator $122,194.96 15
PY2021 Principal investigator $219,308.12 45
PY2020 Principal investigator $152,408.74 95
PY2019 Principal investigator $126,188.89 103

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

95 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $508.29 12/31/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Safety & Efficacy of Empa in patients with Acute HF No dispute reported 06/30/2026 750754473
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 11/20/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902675
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $259.74 11/19/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Safety & Efficacy of Empa in patients with Acute HF No dispute reported 06/30/2026 750754475
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 11/10/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902673
Principal investigator 1 LivaNova USA, Inc. $1,906.25 10/30/2020 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 711977881
Principal investigator 1 Amgen Inc. $950.00 10/23/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY HOSPITAL
GALACTIC - HF No dispute reported 06/30/2026 731632933
Principal investigator 1 LivaNova USA, Inc. $3,450.00 10/21/2020 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 711977879
Principal investigator 1 American Regent $300.00 10/15/2020 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 737107133
Principal investigator 1 Boehringer Ingelheim International GmbH $1,141.00 10/07/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902767
Principal investigator 1 Boehringer Ingelheim International GmbH $49.84 10/02/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902775
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $1,524.87 09/30/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750754465
Principal investigator 1 Boehringer Ingelheim International GmbH $2,839.30 09/17/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902705
Principal investigator 1 LivaNova USA, Inc. $3,612.00 09/11/2020 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 711977675
Principal investigator 1 Boehringer Ingelheim International GmbH $1,203.00 09/10/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902699
Principal investigator 1 Boehringer Ingelheim International GmbH $750.00 09/02/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902701
Principal investigator 1 Boehringer Ingelheim International GmbH $1,000.00 09/02/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902703
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,049.73 08/31/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Safety & Efficacy of Empa in patients with Acute HF No dispute reported 06/30/2026 750754471
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $306.26 08/26/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Safety & Efficacy of Empa in patients with Acute HF No dispute reported 06/30/2026 750754467
Principal investigator 1 Boehringer Ingelheim International GmbH $500.00 08/11/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902709
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $79.20 08/08/2020 Non-covered Recipient Entity
The Research Foundation Of SUNY
Safety & Efficacy of Empa in patients with Acute H No dispute reported 06/30/2026 751189593
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 08/07/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902723
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 08/04/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902689
Principal investigator 1 Boehringer Ingelheim International GmbH $9.27 08/04/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902691
Principal investigator 1 Boehringer Ingelheim International GmbH $9.27 08/04/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902693
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 08/04/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902695
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 08/04/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902697
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 08/04/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902765
Principal investigator 1 Boehringer Ingelheim International GmbH $122.00 08/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902707
Principal investigator 1 Boehringer Ingelheim International GmbH $61.00 08/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902719
Principal investigator 1 Boehringer Ingelheim International GmbH $61.00 08/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902721
Principal investigator 1 Boehringer Ingelheim International GmbH $61.00 08/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902739
Principal investigator 1 Boehringer Ingelheim International GmbH $89.00 08/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902771
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,574.60 07/31/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750754469
Principal investigator 1 Boehringer Ingelheim International GmbH $89.00 07/27/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902711
Principal investigator 1 Boehringer Ingelheim International GmbH $61.00 07/27/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902713
Principal investigator 1 Boehringer Ingelheim International GmbH $61.00 07/27/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902715
Principal investigator 1 Boehringer Ingelheim International GmbH $59.00 07/27/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902717
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $21,310.00 07/09/2020 Non-covered Recipient Entity
The Research Foundation Of SUNY
Safety & Efficacy of Empa in patients with Acute H No dispute reported 06/30/2026 751189591
Principal investigator 1 American Regent $4,356.00 07/08/2020 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 737106803
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 07/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902677
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 07/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902679
Principal investigator 1 Boehringer Ingelheim International GmbH $9.27 07/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902681
Principal investigator 1 Boehringer Ingelheim International GmbH $21.22 07/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902683
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 07/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902685
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 07/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902687
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 06/24/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902741
Principal investigator 1 Novartis Pharmaceuticals Corporation $43,416.09 06/17/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
PROSPECTIVE COMPARISON OF ARNI WITH ARB GIVEN FOLLOWING STABILIZATION IN DECOMPENSATED HFPEF (PARAGLIDE-HFPEF) No dispute reported 06/30/2026 721496071
Principal investigator 1 Boehringer Ingelheim International GmbH $1,301.00 06/16/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902665
Principal investigator 1 Boehringer Ingelheim International GmbH $626.00 06/04/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902667
Principal investigator 1 LivaNova USA, Inc. $1,500.00 05/31/2020 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 711977869
Principal investigator 1 Boehringer Ingelheim International GmbH $776.50 05/22/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902725
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 05/12/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902669
Principal investigator 1 Boehringer Ingelheim International GmbH $626.00 05/12/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902671
Principal investigator 1 Vifor (International) Ltd. $1,250.00 04/20/2020 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750507063
Principal investigator 1 Vifor (International) Ltd. $7,750.00 04/20/2020 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750507065
Principal investigator 1 Vifor (International) Ltd. $1,000.00 04/20/2020 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750507067
Principal investigator 1 Vifor (International) Ltd. $1,000.00 04/20/2020 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750507069
Principal investigator 1 Vifor (International) Ltd. $1,000.00 04/20/2020 Non-covered Recipient Entity
THE RESEARCH FOUNDATION FOR SUNY
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750507071
Principal investigator 1 Boehringer Ingelheim International GmbH $256.00 04/17/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902731
Principal investigator 1 Boehringer Ingelheim International GmbH $1,004.00 04/17/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902733
Principal investigator 1 Boehringer Ingelheim International GmbH $1,004.00 04/17/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902735
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 04/14/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902729
Principal investigator 1 American Regent $300.00 04/08/2020 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 737106709
Principal investigator 1 Boehringer Ingelheim International GmbH $1,035.00 04/01/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902727
Principal investigator 1 Boehringer Ingelheim International GmbH $1,301.00 04/01/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749902737
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 03/31/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750754461
Principal investigator 1 Novartis Pharmaceuticals Corporation $2,750.00 03/18/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
OBSERVATIONAL REGISTRY OF TREATMENT PATTERNS IN US HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION No dispute reported 06/30/2026 721496073
Principal investigator 1 Boehringer Ingelheim International GmbH $1,301.00 03/12/2020 Non-covered Recipient Entity
STONY BROOK UNIV MEDCL CTR
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913997
Principal investigator 1 Boehringer Ingelheim International GmbH $68.00 03/12/2020 Non-covered Recipient Entity
STONY BROOK UNIV MEDCL CTR
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749914001
Principal investigator 1 Boehringer Ingelheim International GmbH $1,035.00 03/11/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902751
Principal investigator 1 American Regent $500.00 03/09/2020 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 737107383
Principal investigator 1 Boehringer Ingelheim International GmbH $10.33 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902753
Principal investigator 1 Boehringer Ingelheim International GmbH $10.33 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902755
Principal investigator 1 Boehringer Ingelheim International GmbH $10.33 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902757
Principal investigator 1 Boehringer Ingelheim International GmbH $10.33 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902759
Principal investigator 1 Boehringer Ingelheim International GmbH $10.33 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902761
Principal investigator 1 Boehringer Ingelheim International GmbH $10.33 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902763
Principal investigator 1 Boehringer Ingelheim International GmbH $10.33 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902769
Principal investigator 1 Boehringer Ingelheim International GmbH $30.99 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIV MEDCL CTR
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749914003
Principal investigator 1 Boehringer Ingelheim International GmbH $30.99 03/03/2020 Non-covered Recipient Entity
STONY BROOK UNIV MEDCL CTR
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749914005
Principal investigator 1 Boehringer Ingelheim International GmbH $309.45 02/25/2020 Non-covered Recipient Entity
STONY BROOK UNIV MEDCL CTR
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913995
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 02/25/2020 Non-covered Recipient Entity
STONY BROOK UNIV MEDCL CTR
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913999
Principal investigator 1 Amgen Inc. $1,840.75 02/22/2020 Non-covered Recipient Entity
RESEARCH FNDTN OF STATE UNIV OF NY
GALACTIC - HF No dispute reported 06/30/2026 731632687
Principal investigator 1 Boehringer Ingelheim International GmbH $103.00 02/14/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902749
Principal investigator 1 LivaNova USA, Inc. $750.00 02/13/2020 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 711977863
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 01/31/2020 Non-covered Recipient Entity
STONY BROOK UNIV MEDCL CTR
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 750756747
Principal investigator 1 LivaNova USA, Inc. $750.00 01/27/2020 Non-covered Recipient Entity
The Research Foundation of State University of New York
ANTHEM HFrEF No dispute reported 06/30/2026 711977861
Principal investigator 1 Amgen Inc. $3,548.11 01/20/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY HOSPITAL
GALACTIC - HF No dispute reported 06/30/2026 731632937
Principal investigator 1 Boehringer Ingelheim International GmbH $1,553.00 01/14/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902743
Principal investigator 1 Boehringer Ingelheim International GmbH $1,465.00 01/14/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902745
Principal investigator 1 Boehringer Ingelheim International GmbH $1,792.00 01/14/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902747
Principal investigator 1 Boehringer Ingelheim International GmbH $776.50 01/14/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749902773
Principal investigator 1 American Regent $6,703.00 01/13/2020 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 737106295
Principal investigator 1 Boehringer Ingelheim International GmbH $512.00 01/13/2020 Non-covered Recipient Entity
STONY BROOK UNIV MEDCL CTR
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749913993
Principal investigator 1 Amgen Inc. $20.16 01/09/2020 Non-covered Recipient Entity
STONY BROOK UNIVERSITY HOSPITAL
GALACTIC - HF No dispute reported 06/30/2026 731632929